MCK McKesson Corporation
company
SEC Filings & Insider Trading Activity 2026

CIK: 927653
Consumer Staples
Wholesale-Drugs, Proprietaries & Druggists' Sundries 59 filings
S&P 500

Latest McKesson Corporation (MCK) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on May 8, 2026, a 10-Q quarterly report filed on February 4, 2026, an 8-K current report filed on August 5, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for McKesson Corporation (MCK) (SEC CIK 927653), with AI-powered section-by-section summaries updated daily.

10-Q: 33
10-K: 12
8-K: 10
SC 13G: 4

Latest 2026 SEC Filing Dates

10-K Annual Report
May 8, 2026
10-Q Quarterly Report
Feb 4, 2026
8-K Current Report
Aug 5, 2026

AI 10-Q Quarterly Report Analysis
Latest 10-Q (2025-12-31)

Management Discussion & Analysis

  • Revenue $106.2B Q2 FY26, up 11% YoY from $95.3B; $307.1B 9M FY26, up 15% YoY from $268.2B
  • Operating margin 1.81% Q2 FY26 vs ~1.52% Q2 FY25 estimated (1,916M profit on 106,158M revenue vs 1,448M on 95,294M)
  • Best segment: Oncology & Multispecialty revenue +37% Q2 ($13.0B vs $9.5B), operating profit +50% Q2 ($304M vs $202M)
  • Worst: Medical-Surgical Solutions revenue +1% Q2 ($3.0B vs $2.9B), operating profit -1% Q2 ($265M vs $269M)
  • Operating cash flow +$4.4B 9M FY26 to $2.7B driven by higher net income and working capital timing; cash used in investing $3.9B mainly acquisitions (Core Ventures $2.5B, PRISM Vision $875M)
  • Management sees sufficient liquidity from $4B revolving credit and other sources; no updated guidance, notes restructuring charges $650-700M to complete by FY28

Risk Factors

  • New operational risk from Rite Aid bankruptcy impact: $29M net charge in provision for bad debts and vendor credits recorded in 3Q FY26
  • Most material update in restructuring charges: $146M in 9M FY26 vs $213M in 9M FY25, reflecting ongoing cost optimization initiatives
  • Legal risk: $108M opioid-related claims charge in 9M FY25, no new charges recognized in 9M FY26, ongoing litigation exposure remains
  • Market risk: 15% revenue growth in 9M FY26 driven by North American Pharmaceutical volume increases and Oncology & Multispecialty specialty pharmaceutical sales
  • Financial risk: Operating expenses decreased 6% in 9M FY26 to $6.44B but SDG&A impacted by acquisitions and disposition of Canadian retail business

Go deeper on McKesson Corporation

Ask AI about MCK filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.

Track institutional money. See which funds are building or cutting MCK positions, quarter over quarter.

Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on MCK.

Annual Reports Archive
10-K

AI-powered analysis of McKesson Corporation (MCK) 10-K annual reports filed with SEC EDGAR.

Quarterly Reports Archive
10-Q

AI-powered analysis of McKesson Corporation (MCK) 10-Q quarterly reports filed with SEC EDGAR.

Recent 8-K Filings
Current Reports

AI-powered analysis of McKesson Corporation (MCK) 8-K current reports disclosing material events.

Financial Summary
XBRL

FY2023FY2024FY2025
Profitability
Revenue-$309.0B$359.1B
Gross Profit-$12.8B$13.3B
Operating Income-$3.9B$4.4B
Net Income-$3.0B$3.3B
Gross Margin-4.2%3.7%
Op. Margin-1.3%1.2%
Net Margin-1.0%0.9%
Balance Sheet
Total Assets$62.3B$67.4B$75.1B
Equity-$1.9B-$2.0B-$2.1B
ROE--152.3%-158.9%
Per Share
EPS-$22.39$25.72
Cash Flow
Operating CF-$4.3B$6.1B
CapEx-$431.0M$537.0M

Source: XBRL financial data from McKesson Corporation (MCK) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling DatePeriodAnalysisSEC
8-K
Aug 5, 2026---
8-K
Jul 24, 2026---
8-K
Jul 1, 2026---
8-K
Jun 12, 2026---
10-K
May 8, 2026Mar 31, 2026-
8-K
May 7, 2026--
8-K
Apr 28, 2026---
8-K
Apr 6, 2026---
8-K
Mar 6, 2026-Analysis-
8-K
Mar 5, 2026-Analysis-
8-K
Feb 4, 2026--
10-Q
Feb 4, 2026Dec 31, 2025Analysis
10-Q
Nov 6, 2025Sep 30, 2025Analysis
10-Q
Aug 6, 2025Jun 30, 2025-
10-K
May 9, 2025Mar 31, 2025Analysis
10-Q
Feb 6, 2025Dec 31, 2024-
10-Q
Nov 7, 2024Sep 30, 2024-
10-Q
Aug 7, 2024Jun 30, 2024-
10-K
May 8, 2024Mar 31, 2024-
10-Q
Feb 8, 2024Dec 31, 2023-
10-Q
Nov 2, 2023Sep 30, 2023-
10-Q
Aug 2, 2023Jun 30, 2023-
10-K
May 9, 2023Mar 31, 2023-
10-Q
Feb 2, 2023Dec 31, 2022-
10-Q
Nov 2, 2022Sep 30, 2022-

13F Fund Holdings: Quarterly Trend

Latest: Q1 2026

Aggregate MCK share value held by 13F filers tracked by SignalX, by quarter.

Position changes: Q4 2025Q1 2026
Top Buyers
Top Sellers
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 380 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.

Frequently Asked Questions

What are the latest MCK SEC filings in 2026?

McKesson Corporation (MCK) has filed a 10-K annual report on May 8, 2026, a 10-Q quarterly report on February 4, 2026, an 8-K current report on August 5, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did MCK file its most recent 10-K annual report?

McKesson Corporation (MCK) filed its most recent 10-K annual report on May 8, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view MCK 10-Q quarterly reports?

McKesson Corporation (MCK)'s most recent 10-Q quarterly report was filed on February 4, 2026. SignalX displays every MCK 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has MCK filed recently?

McKesson Corporation (MCK)'s most recent 8-K was filed on August 5, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find MCK insider trading activity (Form 4)?

SignalX aggregates every MCK Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does MCK file with the SEC?

McKesson Corporation (MCK) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new MCK filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for McKesson Corporation (MCK).

What is MCK's SEC CIK number?

McKesson Corporation (MCK)'s SEC CIK (Central Index Key) number is 927653. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 927653 to look up all MCK filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find MCK return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from McKesson Corporation (MCK) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.

Stay on top of McKesson Corporation SEC filings

Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 59+ filings.